Automating Delirium Severity in the ICU

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorMayo Clinic

About this trial

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age.

The main questions it aims to answer are:

* Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurately measure delirium severity * Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers).

Participants will:

* Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU). * Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.

Eligibility criteria

Qualifiers

Estimated length of stay >24 hours in ICU; and

Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Disqualifiers

Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

Admitted for acute neuronal injury

Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 2 trial groups

Sponsors and collaborators